Posted 22 December 2016 - 08:29 PM
I got a reply from OHSU about the PCR testing. Here's my query:
"In an effort to reduce my medical costs, I was reviewing the ongoing charges for my visits with you. I noticed two BCR-ABL tests listed (80003643 HB-LAB BCR-ABL RNA MAJOR B $287.00 & 80003644 HB-LAB BCR-ABL RNA MINOR B $286.00).
I was wondering if at this point in my treatment are both of these tests necessary to determine the BCR-ABL RNA level in my blood?"
And here's the reply:
I spoke to the lab that runs the test and also to Dr. Heinrich. The two tests that look like they are separate tests (and are billed separately) are really 2 parts to one test. That test is how we monitor your leukemia status and both parts are critical to get the number that we see and that we use to make recommendations as to your treatment. Unfortunately there is not a way to decrease your cost and still do the testing.
You can discuss it further with Dr. Heinrich when you see him on January 9,2017.
If you have other questions or concerns, do not hesitate to contact me.
Florence Seelig, RN, BSN, OCN
Oncology Nurse Coordinator
Oregon Health & Science University"
So I guess that I can't save any money if I keep going to OHSU. Hopefully their profits are being used to fund lots of good research!
9/25/2012 p210 transcript 118.7% IS @ Dx, begin Gleevec 400mg/day
12/2012 3.59% & bone marrow biopsy - no residual myeloproliferative features but detected 1/20 metaphases containing the Philadelphia chromosome
2013 0.914%, 0.434%, 0.412%
10/2013 0.360% & bone marrow biopsy - normal male karyotype with no evidence of a clonal cytogenetic abnormaltiy
2014 0.174%, 0.088%, 0.064%
2015 0.049%, decrease to Gleevec 200mg/day, 0.035%, 0.061%, 0.028%
2016 0.041%, 0.039%, 0.025%
2017 0.029%, 0.039%, switched to generic imatinib 200mg/day, 0.070%, 0.088%